TLDR: Ketryx, a leader in AI-powered compliance for safety-critical industries, has moved to a larger office in Cambridge, Massachusetts. This expansion is a direct response to the escalating demand for its innovative AI agents, which are transforming product development and regulatory adherence in sectors like life sciences and MedTech. The move follows a period of significant growth, marked by new product launches, substantial customer acquisition, and strategic team expansion.
Cambridge, MA – Ketryx, the pioneering force behind AI-powered compliance solutions, has announced its relocation to an expanded office space in Cambridge, Massachusetts. The strategic move comes as the company experiences unprecedented growth, driven by the rapidly increasing adoption of its validated AI agents across highly regulated industries.
The expansion of Ketryx’s physical footprint in Cambridge underscores the surging market demand for its specialized artificial intelligence tools. These AI agents are designed to streamline complex compliance workflows, automate documentation, and accelerate product development cycles for companies operating in safety-critical sectors, including medical devices and life sciences.
Just recently, on May 1, 2025, Ketryx unveiled its first validated AI agents for regulated industries, a significant milestone that promises to revolutionize how companies design, develop, and deploy new products to market. These risk-based agents maintain human oversight for critical decision-making while leveraging AI to generate essential documentation and expedite product delivery. The company’s CEO and founder, Erez Kaminski, previously highlighted the paradox faced by highly regulated companies: ‘the systems and processes in place to ensure safety also weigh them down to the point where product teams across AI, software, and hardware spend most of their time on documentation and compliance instead of innovation.’ Ketryx aims to resolve this by enabling teams to harness AI’s power, likening it to ‘tens of thousands of round-the-clock workers perpetually sifting through every piece of incoming data.’
The company’s growth trajectory has been robust. In 2024, Ketryx marked a pivotal year, expanding its customer base and applications to serve over 20 million patients. This growth was supported by strategic hires, including Zack Jha as SVP of Worldwide Sales, Randall Markham as Chief of Staff, and Gabriel Pascualy as Director of Solutions, all aimed at scaling operations and serving a burgeoning customer base. Ketryx also secured significant funding, including a recent deal in January 2025, providing the capital necessary to fuel its ambitious expansion plans.
The broader industry landscape further validates Ketryx’s growth. A recent IBM study from June 10, 2025, indicated that businesses increasingly view AI agents as essential, not merely experimental, with an anticipated eight-fold surge in AI-enabled workflows by the end of 2025. Executives surveyed expect AI agents to significantly improve process efficiency and output, highlighting a widespread shift towards integrating intelligent automation into core business functions.
Also Read:
- AI Agents Achieve Compliance Milestones, Reshaping Regulatory Landscape and Data Integrity
- LogicFlo Secures $2.7M to Revolutionize Life Sciences Workflows with Compliant AI Agents
Ketryx’s new Cambridge office will accommodate its expanding team and operations, allowing the company to further innovate and meet the escalating global demand for its cutting-edge AI compliance solutions.
